“…The endothelial dysfunction (ED) that occurs in type 1 diabetes mellitus (T1DM) involves numerous and diverse pathogenetic mechanisms including inflammation, hyperglycaemia, production of reactive oxygen species (ROS) and of reactive nitrogen species (RNS), the decrease of nitric oxide (NO) availability or dyslipidemia [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. Endothelial dysfunction is characterised by altered endothelial-dependent relaxation (EDR) produced by the decreased NO levels in the vessel wall [ 8 , 9 , 10 ], a process that leads to micro- and macrovascular complications, increasing significantly the morbidity and mortality in T1DM [ 1 ].…”